Treace Medical Concepts, Inc. (TMCI) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 47.2M | 62.52M | 50.21M | 47.39M | 52.57M | 68.71M | 45.09M | 44.45M | 51.11M | 62.21M | 40.76M | 41.95M |
| Revenue Growth % | -10.22% | -9.01% | 11.37% | 6.6% | 2.86% | 10.44% | 10.62% | 5.96% | 21.12% | 25% | 23.3% | 40% |
| Cost of Goods Sold | 9.79M | 12.12M | 10.51M | 9.63M | 10.68M | 13.23M | 8.95M | 8.78M | 10.13M | 11.47M | 8M | 7.67M |
| COGS % of Revenue | 20.74% | 19.38% | 20.93% | 20.33% | 20.31% | 19.26% | 19.86% | 19.75% | 19.81% | 18.44% | 19.62% | 18.29% |
| Gross Profit | 37.41M | 50.4M | 39.71M | 37.75M | 41.89M | 55.48M | 36.13M | 35.67M | 40.98M | 50.74M | 32.76M | 34.28M |
| Gross Margin % | 79.26% | 80.62% | 79.07% | 79.67% | 79.69% | 80.74% | 80.14% | 80.25% | 80.19% | 81.56% | 80.38% | 81.71% |
| Gross Profit Growth % | -10.71% | -9.15% | 9.89% | 5.83% | 2.23% | 9.33% | 10.29% | 4.07% | 19.98% | 26.77% | 21.49% | 38.91% |
| Operating Expenses | 54.57M | 56.32M | 55.38M | 54.73M | 57.48M | 55.68M | 51.27M | 57.06M | 59.95M | 57.52M | 50.58M | 47.33M |
| OpEx % of Revenue | 115.63% | 90.09% | 110.29% | 115.49% | 109.33% | 81.04% | 113.71% | 128.35% | 117.3% | 92.47% | 124.09% | 112.82% |
| Selling, General & Admin | 49.95M | 51.78M | 49.7M | 49.23M | 51.91M | 50.47M | 46.3M | 51.9M | 54.69M | 53.37M | 46.23M | 43.8M |
| SG&A % of Revenue | 105.83% | 82.82% | 98.98% | 103.89% | 98.75% | 73.46% | 102.7% | 116.75% | 107.01% | 85.79% | 113.42% | 104.41% |
| Research & Development | 4.62M | 4.54M | 4.68M | 5.5M | 5.56M | 5.21M | 4.96M | 5.16M | 5.26M | 4.15M | 4.35M | 3.53M |
| R&D % of Revenue | 9.79% | 7.27% | 9.32% | 11.6% | 10.58% | 7.58% | 11.01% | 11.6% | 10.29% | 6.67% | 10.67% | 8.4% |
| Other Operating Expenses | 0 | 0 | 1000K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -17.17M | -5.92M | -15.68M | -16.97M | -15.58M | -204K | -15.13M | -21.38M | -18.97M | -6.78M | -17.82M | -13.05M |
| Operating Margin % | -36.37% | -9.47% | -31.22% | -35.82% | -29.64% | -0.3% | -33.57% | -48.1% | -37.11% | -10.9% | -43.72% | -31.11% |
| Operating Income Growth % | -10.17% | -2802.94% | -3.58% | 20.62% | 17.85% | 96.99% | 15.06% | -63.82% | -37.69% | -93.94% | -57.43% | -9.38% |
| EBITDA | -16.27M | -3.04M | -12.9M | -14.4M | -13.12M | 2.03M | -12.98M | -19.27M | -17.06M | -5.01M | -16.25M | -11.96M |
| EBITDA Margin % | -34.47% | -4.86% | -25.69% | -30.38% | -24.96% | 2.96% | -28.78% | -43.34% | -33.38% | -8.06% | -39.88% | -28.5% |
| EBITDA Growth % | -23.98% | -249.58% | 0.61% | 25.27% | 23.08% | 140.55% | 20.16% | -61.13% | -32.73% | -94.3% | -49.68% | -3.88% |
| D&A (Non-Cash Add-back) | 899K | 2.88M | 2.78M | 2.58M | 2.46M | 2.24M | 2.16M | 2.12M | 1.91M | 1.77M | 1.56M | 1.09M |
| EBIT | -17.17M | -8.04M | -14.95M | -16.08M | -14.61M | 813K | -14.05M | -19.89M | -17.36M | -4.98M | -16.23M | -10.99M |
| Net Interest Income | -1.07M | -823K | -704K | -546K | -470K | -415K | -246K | 64K | 218K | 405K | 274K | 686K |
| Interest Income | 501K | 527K | 634K | 775K | 841K | 899K | 1.07M | 1.38M | 1.53M | 1.71M | 1.57M | 1.97M |
| Interest Expense | 1.57M | 1.35M | 1.34M | 1.32M | 1.31M | 1.31M | 1.31M | 1.31M | 1.32M | 1.3M | 1.3M | 1.28M |
| Other Income/Expense | -794K | -3.47M | -612K | -424K | -340K | -297K | -226K | 176K | 292K | 501K | 297K | 781K |
| Pretax Income | -17.96M | -9.39M | -16.29M | -17.4M | -15.92M | -501K | -15.36M | -21.21M | -18.68M | -6.28M | -17.52M | -12.27M |
| Pretax Margin % | -38.05% | -15.03% | -32.44% | -36.71% | -30.29% | -0.73% | -34.07% | -47.7% | -36.54% | -10.1% | -42.99% | -29.25% |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -17.96M | -9.39M | -16.29M | -17.4M | -15.92M | -501K | -15.36M | -21.21M | -18.68M | -6.28M | -17.52M | -12.27M |
| Net Margin % | -38.05% | -15.03% | -32.44% | -36.71% | -30.29% | -0.73% | -34.07% | -47.7% | -36.54% | -10.1% | -42.99% | -29.25% |
| Net Income Growth % | -12.81% | -1775.05% | -6.04% | 17.96% | 14.75% | 92.02% | 12.33% | -72.81% | -38.81% | -42.36% | -44.41% | 28.8% |
| Net Income (Continuing) | -17.96M | -9.39M | -16.29M | -17.4M | -15.92M | -501K | -15.36M | -21.21M | -18.68M | -6.28M | -17.52M | -12.27M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.28 | -0.15 | -0.26 | -0.28 | -0.25 | -0.01 | -0.25 | -0.34 | -0.30 | -0.10 | -0.28 | -0.20 |
| EPS Growth % | -12% | - | -4% | 17.65% | 16.67% | 92% | 10.71% | -70% | -36.36% | -58.98% | -21.74% | 35.48% |
| EPS (Basic) | -0.28 | -0.15 | -0.26 | -0.28 | -0.25 | -0.01 | -0.25 | -0.34 | -0.30 | -0.10 | -0.28 | -0.20 |
| Diluted Shares Outstanding | 64.59M | 63.86M | 63.52M | 63.01M | 62.66M | 62.34M | 62.23M | 62.08M | 61.79M | 61.7M | 61.56M | 61.38M |
| Basic Shares Outstanding | 64.59M | 63.86M | 63.52M | 63.01M | 62.66M | 62.34M | 62.23M | 62.08M | 61.79M | 61.7M | 61.56M | 61.38M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |